Cell Culture World Congress 2015

Brochure Available for Cell Culture World Congress

In case you haven’t heard of Cell Culture World, we look at the latest challenges for the upstream sector, the latest technologies and host 20+ interactive sessions for increased networking. Download the programme now for full details. 10 reasons why you should attend: Manuel Carrondo and Alois Jungbauer explore the facility of the future along with other top upstream experts. …

Cortendo Appoints Ruth Thieroff-Ekerdt as Chief Medical Officer

November 19, 2014:  Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today announced the appointment of Ruth Thieroff-Ekerdt, M.D., as Chief Medical Officer effective December 15, 2014. Dr. Thieroff-Ekerdt brings more than 25 years experience across diverse therapeutic areas and orphan diseases in all aspects of drug discovery, development and regulatory approval. She will oversee …

Christmas meet-up announced!

As December approaches we’re feeling festive here at Total Biopharma and we’d like to invite you all to the last industry meet-up for the year. We’re back in Holborn on Tuesday 2nd December for another evening of drinks, snacks and industry networking. Let us buy you a drink to say thanks for your support in 2014, and while you’re at it… …

Godoctr.com connects patients with healthcare providers

Nov 06, 2014: Godoctr.com is a unique and innovative platform to connect patients with healthcare Service Providers (read doctors, clinics, hospitals) in a very simple way. This web based platform simplifies the healthcare selection process for the patients and on the other hand provides a way to  healthcare Service Providers to show case their expertise and reach out to thousand of patients …

DARA BioSciences Product Gelclair® Attains Market Leadership Position in U.S. Retail Market

October 14, 2014: DARA BioSciences, Inc., an oncology supportive care specialty pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatments, announced today that its product, Gelclair®, indicated for the management of  oral mucositis, has attained a major milestone in the U.S. …

Relocation and Upgrade solution for Actavis Malta

Pharmaceutical company Actavis commissioned Extract Technology Ltd to carry out a relocation project as part of its state-of-the-art warehouse at the Bulebel Industrial Estate, Malta. The investment into bigger warehousing facilities was due to a significant increase in the Bulebel site manufacturing output, where volume has practically tripled over the last 7 years. It was therefore imperative for the drug …

Cortendo appoints Robert Lutz as Chief Business Officer

October 9, 2014: Cortendo AB, a global biopharmaceutical company focused on orphan endocrine disorders, announced the appointment of Robert Lutz as Chief Business Officer. Lutz brings deep experience in strategy, forecasting and commercialization from the specialty pharmaceutical industry, including more than a decade at Shire Pharmaceuticals. Lutz will lead the implementation of Cortendo’s commercial strategy for COR-003 (levdexketoconazole), as well as business …

EYLEA® (aflibercept) Injection Receives FDA Approval for Macular Edema Following Retinal Vein Occlusion (RVO)

EYLEA Now Approved for Wet Age-related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and Macular Edema following RVO Oct. 6, 2014: Regeneron Pharmaceuticals, Inc.  today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Retinal Vein Occlusion (RVO), which includes Macular Edema following Branch Retinal Vein Occlusion (BRVO) in addition to the …

Monoclonal Antibodies Market for Gastric and Esophageal Cancers to Double by 2019

September 15, 2014: Reportstack, the leading provider of market research reports has announced pharma industry report on Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 – Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth report. Due to favorable market conditions in terms of US pricing structures and the anticipated approval of a number of late-stage pipeline drugs, the market value …